I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 28% ± 12% | |
| fibroblast | 3 studies | 19% ± 5% | |
| dendritic cell | 3 studies | 26% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 28% ± 12% | |
| fibroblast | 3 studies | 19% ± 5% | |
| dendritic cell | 3 studies | 26% ± 6% |
Insufficient scRNA-seq data for expression of OGFOD3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 1495.50 | 328 / 328 | 100% | 17.95 | 178 / 178 |
| thymus | 100% | 3231.40 | 653 / 653 | 100% | 29.42 | 604 / 605 |
| prostate | 100% | 2330.13 | 245 / 245 | 100% | 33.01 | 501 / 502 |
| skin | 100% | 1692.89 | 1809 / 1809 | 100% | 23.70 | 471 / 472 |
| uterus | 100% | 1999.08 | 170 / 170 | 100% | 20.18 | 458 / 459 |
| liver | 100% | 1253.04 | 226 / 226 | 100% | 15.44 | 405 / 406 |
| kidney | 100% | 1693.37 | 89 / 89 | 100% | 17.83 | 898 / 901 |
| ovary | 100% | 1875.71 | 180 / 180 | 100% | 15.99 | 428 / 430 |
| esophagus | 100% | 1476.78 | 1445 / 1445 | 99% | 11.12 | 182 / 183 |
| lung | 100% | 1653.18 | 577 / 578 | 99% | 19.43 | 1146 / 1155 |
| brain | 99% | 1041.83 | 2616 / 2642 | 100% | 17.47 | 705 / 705 |
| stomach | 100% | 1471.42 | 359 / 359 | 99% | 14.86 | 283 / 286 |
| intestine | 100% | 1622.76 | 966 / 966 | 99% | 17.33 | 521 / 527 |
| breast | 100% | 1763.89 | 459 / 459 | 99% | 21.53 | 1105 / 1118 |
| adrenal gland | 100% | 2264.71 | 258 / 258 | 99% | 21.27 | 227 / 230 |
| bladder | 100% | 1722.81 | 21 / 21 | 99% | 20.83 | 497 / 504 |
| adipose | 100% | 1673.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 21.83 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 14.70 | 29 / 29 |
| muscle | 100% | 1326.35 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1486.39 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 17.67 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 9.25 | 1 / 1 |
| blood vessel | 100% | 1652.98 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 1580.57 | 854 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 83% | 634.95 | 772 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016020 | Cellular component | membrane |
| GO_0005506 | Molecular function | iron ion binding |
| GO_0051213 | Molecular function | dioxygenase activity |
| GO_0016705 | Molecular function | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO_0031418 | Molecular function | L-ascorbic acid binding |
| Gene name | OGFOD3 |
| Protein name | 2-oxoglutarate and iron dependent oxygenase domain containing 3 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 (EC 1.14.11.-) |
| Synonyms | C17orf101 |
| Description | |
| Accessions | Q6PK18 ENST00000313056.10 [Q6PK18-1] K7ELK1 K7ELR2 ENST00000583445.5 ENST00000577495.5 J3QLI8 J3QRG1 ENST00000582593.1 ENST00000329197.9 [Q6PK18-2] ENST00000580445.5 ENST00000583897.5 K7ENS7 |
